Correlation Between Cipher Pharmaceuticals and Nutranomics
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Nutranomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Nutranomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Nutranomics, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Nutranomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Nutranomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Nutranomics.
Diversification Opportunities for Cipher Pharmaceuticals and Nutranomics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cipher and Nutranomics is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Nutranomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nutranomics and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Nutranomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nutranomics has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Nutranomics go up and down completely randomly.
Pair Corralation between Cipher Pharmaceuticals and Nutranomics
If you would invest 0.00 in Nutranomics on August 30, 2024 and sell it today you would earn a total of 0.01 from holding Nutranomics or generate 9.223372036854776E16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 2.33% |
| Values | Daily Returns |
Cipher Pharmaceuticals vs. Nutranomics
Performance |
| Timeline |
| Cipher Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nutranomics |
Cipher Pharmaceuticals and Nutranomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cipher Pharmaceuticals and Nutranomics
The main advantage of trading using opposite Cipher Pharmaceuticals and Nutranomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Nutranomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutranomics will offset losses from the drop in Nutranomics' long position.| Cipher Pharmaceuticals vs. Bionoid Pharma | Cipher Pharmaceuticals vs. Centr Brands Corp | Cipher Pharmaceuticals vs. CTT Pharmaceutical Holdings | Cipher Pharmaceuticals vs. Alterola Biotech |
| Nutranomics vs. Green Cures Botanical | Nutranomics vs. Cann American Corp | Nutranomics vs. Rimrock Gold Corp | Nutranomics vs. Galexxy Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |